Raviglione M,Sulis G .2016 .Tuberculosis 2015: Burden, Challenges and Strategy for Control and Elimination. Infect dis rep, 8 : 6570.
Ramappa V,Aithal GP .2013 .Hepatotoxicity Related to Antituberculosis Drugs: Mechanisms and Management. J clin exp hepatol, 3 : 37-49.
Bloom BR,Atun R,Cohen T,Dye C,Fraser H,Gomez GB,Holmes KK,Bertozzi S,Bloom BR,Jha P .2017 .The International Bank for Reconstruction and Development / The World Bank © 2017 International Bank for Reconstruction. Major Infectious Diseases, : .
Medscape . .Tuberculosis (TB) Treatment & Management. , : .
Li X,Tang J,Mao Y .2022 .Incidence and risk factors of druginduced liver injury. Liver Int, 42 : 1999-2014.
Li M,Luo Q,Tao Y,Sun X,Liu C .2021 .Pharmacotherapies for Drug-Induced Liver Injury: A Current Literature Review. Front pharm, 12 : 806249.
Alqahtani S,Kashkary A,Asiri A,Kamal H,Binongo J,Castro K .2018 .Impact of mobile teams on tuberculosis treatment outcomes. Riyadh Region, Kingdom of Saudi Arabia, 7 : 29-33.
Chen X,Hu TY .2021 .Strategies for advanced personalized tuberculosis diagnosis: Current technologies and clinical approaches. Prec clin med, 4 : 35-44.
Heyckendorf J,Georghiou SB,Frahm N,Heinrich N,Kontsevaya I,Reimann M .2022 .. Tuberculosis Treatment Monitoring and Outcome Measures: New Interest and New Strategies. Clin microbiol rev, 35 : e0022721.
Cohen KA,Manson AL,Desjardins CA,Abeel T,Earl AM .2019 .Deciphering drug resistance in Mycobacterium tuberculosis using whole-genome sequencing: progress, promise, and challenges. Gen Med, 11 : 45.
Tweed CD,Wills GH,Crook AM,Dawson R,Diacon AH,Louw CE .2018 .Liver toxicity associated with tuberculosis chemotherapy in the REMoxTB study. BMC medicine, 16 : 46-9.
Kong X,Guo D,Liu S,Zhu Y,Yu C .2021 .Incidence, characteristics, and risk factors for drug‐induced liver injury in hospitalized patients: A matched case‐control study. Br J Clin Pharmacol, 87 : 4304-12.
Gaude GS,Chaudhury A,Hattiholi J .2015 .Drug-induced hepatitis and the risk factors for liver injury in pulmonary tuberculosis patients. J fam med prim care, 4 : 238-43.
Bao Y,Ma X,Rasmussen TP,Zhong XB .2018 .Genetic Variations Associated with Anti-Tuberculosis DrugInduced Liver Injury. Curr pharmacol rep, 4 : 171-81.
Zhuang X,Li L,Liu T,Zhang R,Yang P,Wang X .2022 .Mechanisms of isoniazid and rifampicin-induced liver injury and the effects of natural medicinal ingredients: A review. Front pharmacol, 13 : 1037814.
Kim JH,Nam WS,Kim SJ,Kwon OK,Seung EJ,Jo JJ .2017 .Mechanism Investigation of Rifampicin-Induced Liver Injury Using Comparative Toxicoproteomics in Mice. Int j mol sci, 18 : .
Abid A,Subhani F,Kayani F,Awan S,Abid S. .2020 .Drug induced liver injury is associated with high mortality-A study from a tertiary care hospital in Pakistan. PloS one, 15 : e0231398.
Cavaco MJ,Alcobia C,Oliveiros B,Mesquita LA,Carvalho A,Matos F .2022 .Clinical and Genetic Risk Factors for Drug-Induced Liver Injury Associated with Anti-Tuberculosis Treatment-A Study from Patients of Portuguese Health Centers. J person med, : 12.
Devarbhavi H.,Drug-Induced Liver H. .2021 .. Clin liver dis, 18 : 108-10.
Moosa MS,Maartens G,Gunter H,Allie S,Chughlay MF,Setshedi M .2022 .Rechallenge after anti-tuberculosis druginduced liver injury in a high HIV prevalence cohort. Southern Afr j HIV med, 23 : 1376.
Clinton JW,Kiparizoska S,Aggarwal S,Woo S,Davis W,Lewis JH .2021 .Drug-Induced Liver Injury: Highlights and Controversies in the Recent Literature. Drug safety, 44 : 1125-49.
Molla Y,Wubetu M,Dessie B .2021 .Anti-Tuberculosis Drug Induced Hepatotoxicity and Associated Factors among Tuberculosis Patients at Selected Hospitals, Ethiopia. Hepatic medicine. evid res, 13 : 1-8.
Saha A,Shanthi FXM,Winston AB,Das S,Kumar A,Michael JS .2016 .Prevalence of Hepatotoxicity from Antituberculosis Therapy: A Five-Year Experience from South India. J prim care commun health, 7 : 171-4.